Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Feb 23;30(5):1018.
doi: 10.3390/molecules30051018.

The Role of Ferulic Acid in Selected Malignant Neoplasms

Affiliations
Review

The Role of Ferulic Acid in Selected Malignant Neoplasms

Anna Markowska et al. Molecules. .

Abstract

Ferulic acid (FA) is a polyphenol that is found in plants and fruits. It has a wide range of anticancer properties, including participating in cell apoptosis, inhibiting invasion and angiogenesis, and acting synergistically with standard cytostatic agents in malignant tumors. A range of molecular mechanisms are involved in anticancer activity and include the following ones: activation of cell-cycle-related proteins and enzymes such as p53, p21, Bax, and pro-caspases 3 and 9, reduction of cyclin D1 and E, proapoptotic Bcl-2, MMP-9, and NF-kV, which decrease VEGF, leading to cell cycle arrest at G0/G1 phase and death of cancer cells. Other mechanisms inhibit several pathways: PI3K/AKT/mTOR, Notch, and Wnt, which are associated with downregulation of proliferation, invasion, metastasis, and angiogenesis. FA can induce activation of ROS, leading to DNA damage in cancer cells. In vitro and in vivo studies have demonstrated the significant antitumor activity of FA in breast cancer, particularly when used in combination with cytostatic agents. In vitro studies on cervical cancer cell lines have reported similar anticancer activity of FA. This includes inhibition of cell proliferation and induction of apoptosis by downregulating antiapoptotic proteins. A case-control study conducted in Italy found that men with histologically confirmed prostate cancer had notably lower levels of FA compared to controls. Molecular in vitro studies have suggested that FA may have various effects on the signaling pathways linked to a reduction in the risk of prostate cancer, and it may act in synergy with δ-tocotrienol, which is a derivative of vitamin E. In vivo and in vitro studies on colorectal cancer have demonstrated the effects of FA on the early development of this cancer-inhibition of abnormal crypt foci (ACF-aberrant crypt foci), as well as the reduction in cancer cell viability and apoptosis through molecular changes, mainly a decrease in EGFR expression. The poor water solubility of FA makes it an attractive candidate for use as nanoparticles.

Keywords: anticancer activity; breast cancer; cervical cancer; colon cancer; ferulic acid (FA); flavonoids; prostate cancer.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Chemical structural formula for the FA molecule with various sources and health properties.
Figure 2
Figure 2
Simplified scheme of FA’s impact on the DNA of cancer cells.
Figure 3
Figure 3
Known cellular mechanisms and effects of FA application on breast cancer. ?—elements of cellular mechanisms have not been revealed yet; red arrow heading down—diminished cellular effect; REF.—references: Zhang et al. (2016) [2], Yang et al. (2015) [18], Meirelles et al. (2023) [27], Sudhagar et al. (2018) [28], Rezaei et al. (2019) [29], Helmy et al. (2022) [30].
Figure 4
Figure 4
Known cellular mechanisms and effects of FA application on cervical cancer. ?—elements of cellular mechanisms have not been revealed yet; blue arrow heading up—enhanced cellular effect; red arrow heading down—diminished cellular effect; REF.—references: Gupta et al. (2021) [6], Gao et al. (2018) [32], Luo et al. (2020) [33], Wang et al. (2022) [34].
Figure 5
Figure 5
Known cellular mechanisms and effects of FA application on prostate cancer. ?—elements of cellular mechanisms have not been revealed yet; blue arrow heading up—enhanced cellular effect; REF.—references: Eroglu et al. (2015) [36], Eitsuka et al. (2014) [37].
Figure 6
Figure 6
Known cellular mechanisms and effects of FA application on colorectal cancer. ?—elements of cellular mechanisms have not been revealed yet; red arrow heading down—diminished cellular effect; REF.—references: Gupta et al. (2021) [6], Kawabata et al. (2000) [38], Janicke et al. (2005) [39], Roy et al. (2016) [40], Rosa et al. (2018) [41], Sawata et al. (2019) [42].
Figure 7
Figure 7
A summary of in vivo studies of ferulic acid application in cancer treatment—FA dosage and its resulting effects on cancer cells: (A) ferulic acid administration to mice for breast cancer treatment; (B) ferulic acid administration to rats for colorectal cancer treatment. Arrow heading up—enhanced effect; arrow heading down—diminished effect. The figures were prepared according to the information provided by (A) Zhang et al. (2016) [2] and (B) Kawabata et al. 2000 [38].

References

    1. Shen N., Wang T., Gan Q., Liu S., Wang L., Jin B. Plant flavonoids: Classification, distribution, biosynthesis, and antioxidant activity. Food Chem. 2022;383:132531. doi: 10.1016/j.foodchem.2022.132531. - DOI - PubMed
    1. Zhang X., Lin D., Jiang R., Li H., Wan J., Li H. Ferulic acid exerts antitumor activity and inhibits metastasis in breast cancer cells by regulating epithelial to mesenchymal transition. Oncol. Rep. 2016;36:271–278. doi: 10.3892/or.2016.4804. - DOI - PubMed
    1. Babbar R., Dhiman S., Grover R., Kaur A., Arora S. Comprehensive Review on Therapeutic Applications of Ferulic Acid and its Novel Analogues: A Brief Literature. Mini Rev. Med. Chem. 2021;21:1578–1593. doi: 10.2174/1389557521666210120111702. - DOI - PubMed
    1. Zhang L., Han Z., Granato D. Polyphenols in foods: Classification, methods of identification, and nutritional aspects in human health. Adv. Food Nutr. Res. 2021;98:1–33. doi: 10.1016/bs.afnr.2021.02.004. - DOI - PubMed
    1. Harms L.M., Scalbert A., Zamora-Ros R., Rinaldi S., Jenab M., Murpy N., Achaintre D., Jønneland A., Olsen A., Overvad K., et al. Plasma polyphenols associated with lower high-sensitivity C-reactive protein concentrations: A cross-sectional study within the European Prospective Investigation into Cancer and Nutrition. Br. J. Nutr. 2020;123:198–208. doi: 10.1017/S0007114519002538. - DOI - PMC - PubMed